+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • PDF Icon

    Report

  • 150 Pages
  • January 2024
  • Region: Global
  • Lucintel
  • ID: 5929132

Infectious Disease Diagnostics Trends and Forecast

The future of the global infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets. The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

Infectious Disease Diagnostics by Segment

The study includes a forecast for the global infectious disease diagnostics by product, test type, technology, end use, and region.

Infectious Disease Diagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]

  • Reagents, Kits, and Consumables
  • Instruments
  • Software & Services

Infectious Disease Diagnostics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]

  • Lab
  • POC

Infectious Disease Diagnostics Market by Technology [Shipment Analysis by Value from 2018 to 2030]

  • Immunodiagnostics
  • NGS
  • INAAT
  • PCR

Infectious Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]

  • Hospitals
  • Labs

Infectious Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Infectious Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infectious disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infectious disease diagnostics companies profiled in this report include-
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMérieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Infectious Disease Diagnostics Market Insights

The publisher forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Within this market, immunodiagnostics will remain the largest segment due to increasing usage of immunoassays in covid-19 testing, POC infectious disease testing, and others.

North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Features of the Global Infectious Disease Diagnostics Market

  • Market Size Estimates: Infectious disease diagnostics market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Infectious disease diagnostics market size by various segments, such as by product, test type, technology, end use, and region in terms of value ($B).
  • Regional Analysis: Infectious disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, test types, technologies, end uses, and regions for the infectious disease diagnostics market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infectious disease diagnostics market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the infectious disease diagnostics market size?
Answer: The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030.

Q2. What is the growth forecast for infectious disease diagnostics market?
Answer: The global infectious disease diagnostics market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the infectious disease diagnostics market?
Answer: The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

Q4. What are the major segments for infectious disease diagnostics market?
Answer: The future of the infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets.

Q5. Who are the key infectious disease diagnostics market companies?
Answer: Some of the key infectious disease diagnostics companies are as follows:
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMérieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson
Q6. Which infectious disease diagnostics market segment will be the largest in future?
Answer: The publisher forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Q7. In infectious disease diagnostics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Q.8 Do we receive customization in this report?
Answer: Yes,the publisher provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the infectious disease diagnostics market by product (reagents, kits, and consumables, instruments, and software & services), test type (lab and POC), technology (immunodiagnostics, NGS, INAAT, and PCR), end use (hospitals and labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
2. Global Infectious Disease Diagnostics Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Infectious Disease Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Infectious Disease Diagnostics Market by Product
3.3.1: Reagents, Kits, and Consumables
3.3.2: Instruments
3.3.3: Software & Services
3.4: Global Infectious Disease Diagnostics Market by Test Type
3.4.1: Lab
3.4.2: POC
3.5: Global Infectious Disease Diagnostics Market by Technology
3.5.1: Immunodiagnostics
3.5.2: NGS
3.5.3: INAAT
3.5.4: PCR
3.6: Global Infectious Disease Diagnostics Market by End Use
3.6.1: Hospitals
3.6.2: Labs
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Infectious Disease Diagnostics Market by Region
4.2: North American Infectious Disease Diagnostics Market
4.2.1: North American Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
4.3: European Infectious Disease Diagnostics Market
4.3.1: European Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
4.3.2: European Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
4.4: APAC Infectious Disease Diagnostics Market
4.4.1: APAC Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
4.4.2: APAC Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
4.5: ROW Infectious Disease Diagnostics Market
4.5.1: ROW Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
4.5.2: ROW Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Product
6.1.2: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Test Type
6.1.3: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Technology
6.1.4: Growth Opportunities for the Global Infectious Disease Diagnostics Market by End Use
6.1.5: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Region
6.2: Emerging Trends in the Global Infectious Disease Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Infectious Disease Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Infectious Disease Diagnostics Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Abbott Laboratories
7.2: Thermo Fisher Scientific
7.3: F. Hoffmann-La Roche
7.4: bioMérieux
7.5: Siemens Healthineers
7.6: Danaher Corporation
7.7: Becton and Dickinson

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMérieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Methodology

The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:

  • In-depth interviews of the major players in the market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.

Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.

Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

 

Loading
LOADING...